R&D Projects

Posted By :
Comments : 0

logoOptogenerapy (3)

The goal of OPTOGENERAPY project (Optogenic Protein Therapy for Multiple Sclerosis) is to develop and demonstrate a new optogenetics implant for controlled beta interferon (IFN- ß) protein delivery for treating patients suffering from multiple sclerosis. The new implant will be the result of the cooperation of 11 European partners, including Universities, Tech centres, Health institutions, SMEs and big companies.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 720694
logo-ce-horizontal-en-quadri-lr (002)







Ultrasion participates in the Project   PAT15-1-0020  “Sonorus 2G: màquina de micro-injecció de termoplàstics per ultrasons”.
Initiative sponsored with the aid of         ACCIÓ horitzontal color
About the Author